APA (7th ed.) Citation

MA, L., SONG, K., & ZANG, J. (2023). Integrin β5 is an independent prognostic marker for intrahepatic cholangiocarcinoma in a Chinese population. Experimental & Therapeutic Medicine, 26(5), 1. https://doi.org/10.3892/etm.2023.12231

Chicago Style (17th ed.) Citation

MA, LIXING, KANG SONG, and JINFENG ZANG. "Integrin β5 Is an Independent Prognostic Marker for Intrahepatic Cholangiocarcinoma in a Chinese Population." Experimental & Therapeutic Medicine 26, no. 5 (2023): 1. https://doi.org/10.3892/etm.2023.12231.

MLA (9th ed.) Citation

MA, LIXING, et al. "Integrin β5 Is an Independent Prognostic Marker for Intrahepatic Cholangiocarcinoma in a Chinese Population." Experimental & Therapeutic Medicine, vol. 26, no. 5, 2023, p. 1, https://doi.org/10.3892/etm.2023.12231.